Work

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

Year: 2024

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-4047331/v1

Authors: Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, Alan Venook, Ahmad Samiei, Andrew Nixon, Joseph Lucci 3rd, Scott Kopetz, Monica Bertagnolli, Charles Perou, Federico Innocenti

Institutions: Brigham and Women's Hospital, Texas Medical Center, National Institute of Environmental Health Sciences, University of Padua, Iran University of Science and Technology, University of Southern California, University of California, San Francisco, Duke University, The University of Texas MD Anderson Cancer Center, UNC Lineberger Comprehensive Cancer Center, AbbVie (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, National Institutes of Health, Genentech, National Cancer Institute

Awards: G2350719019, G4185274752, G8225661566, Alliance for Clinical Trials in Oncology Operations Center, G9000025006

OpenAlex ID: W4392642267

Cites: 19

Cited by: 2

Related to: 10